Pharmafile Logo
Pharmafocus logo
Advanced Search
China manufacturing

FDA alleges records cover-up at Chinese Pfizer plant

November 3, 2015
Manufacturing and Production FDA, Pfizer, compliance, inspection, manufacturing, production, regulations

The FDA has discovered violations at a Pfizer plant in China, including the use of out-of-date materials and record- keeping …

News
3D printer

Featured market report: 3D printing market summary

November 2, 2015
Manufacturing and Production 3d printing, manufacturing, medical devices, production

The global 3D printing medical devices market is estimated to grow at a CAGR of 25.3% from 2015 to 2020.The …

Feature
Shire

Shire to acquire Dyax in $5.9 billion deal

November 2, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease

Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …

News
neil_brewis_photo

Biopharma firm F-star appoints Dr Neil Brewis as CSO

November 2, 2015
Manufacturing and Production, Research and Development F-star, Neil Brewis

F-star, a biopharma company focused on immuno-oncology, has hired Dr Neil Brewis as chief scientific officer. Dr Brewis is a former vice …

Appointment
mark_filip

Former Deputy Attorney General called in to advise Valeant after fraud allegations

November 2, 2015
Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud

Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …

Appointment
Allergan

Allergan subsidiary president arrested on kickback charges

November 2, 2015
Sales and Marketing Allergan, US District Court, Warner Chilcott, fraud, healthcare fraud

Allergan subsidiary Warner Chilcott will plead guilty to a US felony charge of healthcare fraud, and settle a case of …

News
EU flag

European Commission funds €23m project to develop HIV vaccine

November 2, 2015
Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020

The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …

News
eylea

Bayer, Regeneron’s Eylea gets additional EU indication

November 2, 2015
Research and Development, Sales and Marketing Bayer, Eylea, Regeneron

The European Commission has granted a fifth indication to Bayer and Regeneron’s eye drug Eylea (aflibercept injection), which is now …

News
Vidaza product image

Celgene’s Vidaza earns wider approval

November 2, 2015
Sales and Marketing Celgene, European Commission, Vidaza, acute myeloid leukaemia, azacitidine, leukaemia

Swiss firm Celgene has been given approval by the European Commission to extend its marketing authorisation for the cancer treatment …

News
Merck R&D

Merck and Selvita form oncology partnership

November 2, 2015
Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology

Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …

News
abbvie_0

AbbVie reports 26% rise in Q3 revenues

October 30, 2015
Sales and Marketing AbbVie, Humira

AbbVie has announced stronger-than-anticipated Q3 financial results, its revenues increasing 26.2% on the same period last year to $5.944 billion, …

News
pillsphotos1

The pharmaceutical ethics of drug-price increases

October 30, 2015
Medical Communications, Research and Development Drug pricing, Turing Pharma, ethics

What is an ‘ethical’ price for a drug?Last month Turing Pharmaceuticals, a start-up run by a former hedge-fund manager, raised …

Feature
Phase III trial

FDA approves new therapy for pancreatic cancer

October 30, 2015
Medical Communications, Sales and Marketing FDA, Pancreatic cancer

The FDA has approved drug a pancreatic cancer drug, Onivyde, which has produced significant overall survival rates in an international …

News
valeant_logo

Valeant drops Philidor after prescription fraud row

October 30, 2015
Medical Communications, Sales and Marketing Valeant

Valeant has announced that it is ‘severing all ties with Philidor’, the specialty pharmacy at the heart of recent controversy surrounding …

News

NHS set for digital health tech review

October 30, 2015
Medical Communications Jeremy Hunt, NHS, Robert Wachter, digital health, health secretary

Health secretary Jeremy Hunt says turning the NHS into a “patient-powered, technologically advanced health service” is “one of the most …

News
Project EVO

Digital software shows benefit in ADHD trial

October 30, 2015
Medical Communications ADHD, Akili, PureTech Health, attention deficit hyperactivity disorder, digital tech

A pilot study of a digital health technology designed to improve symptoms of attention deficit hyperactivity disorder (ADHD) in children …

News
sanofi_logo_vertical_2011_4colors-web

Sanofi recalls allergy injection pens

October 29, 2015
Manufacturing and Production Allerject, Sanofi, anaphylaxis

Sanofi has halted manufacturing and is recalling its Allerject auto-injectors following a blunder involving incorrect dosages. The voluntary recall involves …

News
faysal_kamoua

Alvogen appoints Faysal Kalmoua as EVP of portfolio

October 29, 2015
Medical Communications Alvogen, Faysal Kalmoua

Alvogen has announced the appointment of Faysal Kalmoua as its new executive vice president of portfolio.Kalmoua joins Alvogen with an …

Appointment
Constella

Allergan acquires rights to pioneering IBS treatment from Almirall

October 29, 2015
Medical Communications, Sales and Marketing Allergan, Constella, IBS, linaclotide

Allergan and its commercialisation partner Ironwood Pharmaceuticals have announced that Allergan has acquired the rights to Constella.The companies have acquired …

News
Coins

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …

Feature
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026